Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

189

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
C02KX01	TRACLEER	B	Bosentan (monohydrate) - 125mg	125mg	Tablet, film coated	79,583,961 L.L
C02KX01	BOSENTAN ARROW	G	Bosentan (monohydrate) - 125mg	125mg	Tablet, film coated	51,483,159 L.L
C02KX01	PMS-BOSENTAN	G	Bosentan (monohydrate) - 125mg	125mg	Tablet	77,539,821 L.L
C02KX01	TRACTAN	G	Bosentan (monohydrate) - 125mg	125mg	Tablet, film coated	47,747,570 L.L
C02KX01	BOSENTAN ARROW	G	Bosentan (monohydrate) - 125mg	125mg	Tablet, film coated	L.L
C02KX01	TRACLEER	B	Bosentan (monohydrate) - 62.5mg	62.5mg	Tablet, film coated	79,583,961 L.L
C02KX01	TRACLEER	B	Bosentan (monohydrate) - 62.5mg	62.5mg	Tablet, film coated	79,583,961 L.L
C02KX01	BOSENTAN ARROW	G	Bosentan (monohydrate) - 62.5mg	62.5mg	Tablet, film coated	51,483,159 L.L
C02KX01	PMS-BOSENTAN	G	Bosentan (monohydrate) - 62.5mg	62.5mg	Tablet	77,539,821 L.L
C02KX01	TRACTAN	G	Bosentan (monohydrate) - 62.5mg	62.5mg	Tablet, film coated	47,747,570 L.L
C02KX01	BOSENTAN ARROW	G	Bosentan (monohydrate) - 62.5mg	62.5mg	Tablet, film coated	L.L
L01EA04	BOSULIF	B	Bosutinib - 100mg	100mg	Tablet, film coated	35,663,747 L.L
L01EA04	BOSULIF	B	Bosutinib - 100mg	100mg	Tablet, film coated	L.L
L01EA04	BOSULIF	B	Bosutinib - 400mg	400mg	Tablet, film coated	123,564,667 L.L
L01EA04	BOSULIF	B	Bosutinib - 400mg	400mg	Tablet, film coated	L.L
L01EA04	BOSULIF	B	Bosutinib - 500mg	500mg	Tablet, film coated	154,453,246 L.L
L01EA04	BOSULIF	B	Bosutinib - 500mg	500mg	Tablet, film coated	L.L
L01FX05	ADCETRIS	BioTech	Brentuximab Vedotin - 50mg	50mg	Injectable powder for concentrate for solution	L.L
L01FX05	ADCETRIS	BioTech	Brentuximab Vedotin - 50mg	50mg	Injectable powder for concentrate for solution	298,266,862 L.L
L01ED04	ALUNBRIG	B	Brigatinib - 180mg	180mg	Tablet, film coated	493,595,998 L.L
L01ED04	ALUNBRIG	B	Brigatinib - 30mg	30mg	Tablet, film coated	124,685,776 L.L
L01ED04	ALUNBRIG	B	Brigatinib - 90mg	90mg	Tablet, film coated	374,059,747 L.L
S01EA05	LUMIFY	B	Brimonidine tartrate - 0.025%		Drops solution	1,888,099 L.L
S01EA05	ALPHAGAN P	B	Brimonidine tartrate - 0.1%	0.15%	Drops solution	999,819 L.L
S01EA05	ALPHANOVA	G	Brimonidine tartrate - 0.15%	0.15%	Drops solution	599,354 L.L
S01EA05	BGLAU	G	Brimonidine tartrate - 0.2%	0.2%	Drops solution	638,325 L.L
S01EA05	BRIMO	G	Brimonidine tartrate - 0.2%	0.2%	Drops solution	658,483 L.L
S01EA05	BRIMOGAN	G	Brimonidine tartrate - 0.2% w/v	0.2% w/v	Drops solution	483,783 L.L
S01EA05	ALPHAGAN P	B	Brimonidine tartrate - 1.5mg/ml	0.15%	Drops solution	999,819 L.L
S01EA05	ALPHAGAN P	B	Brimonidine tartrate - 1.5mg/ml	0.15%	Drops solution	999,819 L.L

...

189